Giuseppina Mele

896 total citations
41 papers, 698 citations indexed

About

Giuseppina Mele is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Giuseppina Mele has authored 41 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 9 papers in Public Health, Environmental and Occupational Health and 8 papers in Genetics. Recurrent topics in Giuseppina Mele's work include Acute Myeloid Leukemia Research (24 papers), Hematopoietic Stem Cell Transplantation (18 papers) and Acute Lymphoblastic Leukemia research (9 papers). Giuseppina Mele is often cited by papers focused on Acute Myeloid Leukemia Research (24 papers), Hematopoietic Stem Cell Transplantation (18 papers) and Acute Lymphoblastic Leukemia research (9 papers). Giuseppina Mele collaborates with scholars based in Italy, Germany and United States. Giuseppina Mele's co-authors include Felicetto Ferrara, Salvatore Palmieri, Salvatore Mirto, Mario Annunziata, Barbara Pocali, Marco Montillo, Ettore Mariano Schiavone, Mariacarla De Simone, Vincenzo Mettivier and António E. Pinto and has published in prestigious journals such as Blood, Cancer and Annals of Oncology.

In The Last Decade

Giuseppina Mele

40 papers receiving 676 citations

Peers

Giuseppina Mele
E. Winton United States
O. Krieger Austria
Peter Bojko Germany
P R Taylor United Kingdom
Hyeoung-Joon Kim South Korea
J. Bickers United States
E. Winton United States
Giuseppina Mele
Citations per year, relative to Giuseppina Mele Giuseppina Mele (= 1×) peers E. Winton

Countries citing papers authored by Giuseppina Mele

Since Specialization
Citations

This map shows the geographic impact of Giuseppina Mele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppina Mele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppina Mele more than expected).

Fields of papers citing papers by Giuseppina Mele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppina Mele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppina Mele. The network helps show where Giuseppina Mele may publish in the future.

Co-authorship network of co-authors of Giuseppina Mele

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppina Mele. A scholar is included among the top collaborators of Giuseppina Mele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppina Mele. Giuseppina Mele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrara, Felicetto, et al.. (2010). Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: Feasibility, toxicity, and therapeutic results. American Journal of Hematology. 85(9). 687–690. 6 indexed citations
2.
Camera, Andrea, Ciro R. Rinaldi, Salvatore Palmieri, et al.. (2008). Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients. Annals of Hematology. 88(2). 151–158. 18 indexed citations
3.
Palmieri, Salvatore, Alfonso Maria D’Arco, Giuseppina Mele, et al.. (2006). An antecedent diagnosis of refractory anemia with excess blasts has no prognostic relevance in acute myeloid leukemia of older adult patients. Annals of Oncology. 17(7). 1146–1151. 6 indexed citations
4.
Ferrara, Felicetto, et al.. (2006). Feasibility of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia. Leukemia & lymphoma. 47(8). 1593–1598. 11 indexed citations
5.
Ferrara, Felicetto, Carmine Selleri, Giuseppina Mele, et al.. (2004). Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two cases. Annals of Hematology. 83(7). 484–486. 7 indexed citations
6.
Pocali, Barbara, Mariacarla De Simone, Mario Annunziata, et al.. (2004). Ifosfamide, Epirubicin and Etoposide (IEV) Regimen as Salvage and Mobilization Therapy for Refractory or Early Relapsing Patients with Aggressive Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 45(8). 1605–1609. 14 indexed citations
7.
Ferrara, Felicetto, et al.. (2004). High‐dose idarubicin and busulphan as conditioning to autologous stem cell transplantation in adult patients with acute myeloid leukaemia. British Journal of Haematology. 128(2). 234–241. 17 indexed citations
8.
Palmieri, Salvatore, Giuseppina Mele, Mario Annunziata, et al.. (2002). High-dose cytarabine as consolidation treatment for patients with acute myeloid leukemia with t(8;21). Leukemia Research. 26(6). 539–543. 12 indexed citations
9.
Ferrara, Felicetto, Salvatore Palmieri, Barbara Pocali, et al.. (2002). De novo acute myeloid leukemia with multilineage dysplasia: treatment results and prognostic evaluation from a series of 44 patients treated with fludarabine, cytarabine and G‐CSF (FLAG). European Journal Of Haematology. 68(4). 203–209. 31 indexed citations
10.
Ferrara, Felicetto, Mario Annunziata, Salvatore Palmieri, et al.. (2001). Vincristine as treatment for recurrent episodes of thrombotic thrombocytopenic purpura. Annals of Hematology. 81(1). 7–10. 24 indexed citations
11.
Ferrara, Felicetto, Mario Annunziata, Ettore Mariano Schiavone, et al.. (2001). High-dose idarubicin and busulphan as conditioning for autologous stem cell transplantation in acute myeloid leukemia: a feasibility study. The Hematology Journal. 2(4). 214–219. 9 indexed citations
12.
Ferrara, Felicetto, Lorella Melillo, Marco Montillo, et al.. (1999). Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of acute myeloid leukemia relapsing after autologous stem cell transplantation. Annals of Hematology. 78(8). 380–384. 34 indexed citations
13.
Ferrara, Felicetto, Mario Annunziata, Anna Spasiano, et al.. (1999). Vincristine as salvage treatment for refractory thrombotic thrombocytopenic purpura. Annals of Hematology. 78(11). 521–523. 32 indexed citations
14.
Annunziata, Mario, et al.. (1998). Therapeutic options and treatment results for patients over 75 years of age with acute myeloid leukemia.. PubMed. 83(2). 126–31. 31 indexed citations
15.
Montillo, Marco, Salvatore Mirto, Maria Concetta Petti, et al.. (1998). Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia. American Journal of Hematology. 58(2). 105–109. 94 indexed citations
16.
Mele, Giuseppina, et al.. (1997). [Early diagnosis of endometrial carcinoma and its precursors in asymptomatic postmenopausal women. Proposal of a diagnostic protocol].. PubMed. 49(4). 133–7. 1 indexed citations
17.
Ferrara, Felicetto, et al.. (1992). Recombinant interferon‐α2A as maintenance treatment for patients with advanced stage chronic lymphocytic leukemia responding to chemotherapy. American Journal of Hematology. 41(1). 45–49. 14 indexed citations
18.
Ferrara, Felicetto, R Cimino, Giuseppina Mele, et al.. (1992). Clinical relevance of immunological dissection in T‐ALL: A report on 20 cases with stem cell (CD7+, CD4‐, CD8‐, CD1‐) phenotype. American Journal of Hematology. 40(2). 98–102. 10 indexed citations
19.
Ferrara, Felicetto, et al.. (1990). Acute Myeloid Leukemia Expressing T-Cell Antigens: Clinico-Hematological Report on Six Cases. Leukemia & lymphoma. 3(3). 217–222. 12 indexed citations
20.
Mele, Giuseppina, et al.. (1987). Effectiveness and tolerability of ketoprofen lysine, once a day, in patients with rheumatic disorders.. PubMed. 13(5). 293–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026